These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 80525)

  • 1. Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients.
    Bolli P; Simpson FO; Waal-Manning HJ
    Lancet; 1978 Sep; 2(8090):595-8. PubMed ID: 80525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function.
    Br J Clin Pharmacol; 1983 May; 15(5):513-8. PubMed ID: 6344896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension.
    Pearson RM; Bulpitt CJ; Havard CW
    Lancet; 1979 Mar; 1(8118):697-9. PubMed ID: 85937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of arterial hypertension with tienilic acid, a new diuretic with uricosuric properties.
    Lemieux G; Beauchemin M; Gougoux A; Vinay P
    Can Med Assoc J; 1978 May; 118(9):1074-8. PubMed ID: 25707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One year follow-up of hyperuricaemic hypertensive patients treated with tienilic acid or a diuretic with or without uric acid-lowering drugs.
    Waal-Manning HJ; Simpson FO
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():379s-382s. PubMed ID: 396085
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with a new hypouricemic diuretic (tienilic acid): comparison with hydrochlorothiazide].
    Furrer J; Vetter W; Siegenthaler W
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1983-7. PubMed ID: 373100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of equivalent antihypertensive doses of mefruside and cyclopenthiazide on serum electrolytes, uric acid and glucose tolerance in hypertensive patients.
    Waal-Manning HJ
    Clin Exp Pharmacol Physiol; 1975; 2(2):141-6. PubMed ID: 1095262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on tienilic acid in hypertensive hyperuricaemic patients in Dunedin, New Zealand.
    Waal-Manning HJ; Bolli P; Wood AJ; Simpson FO
    Postgrad Med J; 1979; 55 Suppl 3():85-91. PubMed ID: 388401
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone.
    Roberts CJ; Marshall AJ; Heaton S; Barritt DW
    Br Med J; 1979 Jan; 1(6158):224-6. PubMed ID: 369652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects in man of tienilic acid, a new diuretic with uricosuric properties.
    Lemieux G; Gougoux A; Vinay P; Kiss A; Baverel G
    Nephron; 1978; 20(1):54-64. PubMed ID: 619301
    [No Abstract]   [Full Text] [Related]  

  • 11. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
    McVeigh G; Galloway D; Johnston D
    BMJ; 1988 Jul; 297(6641):95-8. PubMed ID: 3044503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
    Wray R; Benton KG; Whitehill D; Wright B; Weener W; Whittington JR
    Curr Med Res Opin; 1983; 8(9):665-74. PubMed ID: 6365467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre comparative trial of tienilic acid and hydrochlorothiazide in hypertensive patients.
    Ponticelli C; Lechi A; di Perri T; Redaelli B; Locatelli F; Rivolta E; Covi G; Messa GL; Pincella G; Pedrini L; Recchia M; Gouère P
    Eur J Clin Pharmacol; 1979 Nov; 16(5):319-22. PubMed ID: 391578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of tienilic acid, a new diuretic uricosuric agent, in the therapy of arterial hypertension.
    Lechi A; Covi G; Danti G; Riva AD; Pedrolli E; Pomari S
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():367s-269s. PubMed ID: 396083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH
    S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low versus conventional dose cyclopenthiazide on platelet intracellular calcium in mild essential hypertension.
    McVeigh GE; Copeland S; McKellar J; Johnston D
    J Hypertens; 1988 Apr; 6(4):337-41. PubMed ID: 3288695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension.
    Seedat YK; Seedat MA; Bhoola R
    Curr Med Res Opin; 1977; 4(9):627-9. PubMed ID: 590023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tienilic acid in patients with impaired renal function.
    Eisalo A; Tötterman KJ; Haapanen E
    Acta Med Scand Suppl; 1982; 668():110-3. PubMed ID: 6762807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of ticrynafen and hydrochlorothiazide in the treatment of hypertension.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents
    N Engl J Med; 1979 Aug; 301(6):293-7. PubMed ID: 377081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
    Elsdon-Dew RW; Holden E
    J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.